Social influences on plasma testosterone levels in morphine withdrawn adolescent mice and their drug-naïve cage-mates

Psychoneuroendocrinology

Volumn 36, Issue 5, 2011, Pages 728-736

  Hofford, Rebecca S ^a   Wellman, Paul J ^a   Eitan, Shoshana ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Age dependent; Corticosterone; Drug addiction; Opioid; Pain management; Peer influences

Indexed keywords

CORTICOSTERONE; MORPHINE; SODIUM CHLORIDE; TESTOSTERONE;

ADOLESCENT; AGE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFECT; DRUG WITHDRAWAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOCIAL ASPECT; TESTOSTERONE BLOOD LEVEL;

AGE FACTORS; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; HEALTH; HOUSING, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MORPHINE; MORPHINE DEPENDENCE; SEXUAL MATURATION; SOCIAL BEHAVIOR; SOCIAL ENVIRONMENT; SUBSTANCE WITHDRAWAL SYNDROME; TESTOSTERONE;

EID: 79955524665     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.10.008     Document Type: Article

References (67)

1. Abs R., Verhelst J., Maeyaert J., Van Buyten J.-P., Opsomer F., Adriaensen H., Verlooy J., Van Havenbergh T., Smet M., Van Acker K. Endocrine consequences of long-term intrathecal administration of opioids. J. Clin. Endocrinol. Metab. 2000, 85:2215-2222.
2. Adams M.L., Sewing B., Forman J.B., Meyer E.R., Cicero T.J. Opioid-induced suppression of rat testicular function. J. Pharmacol. Exp. Ther. 1993, 266:323-328.
3. Aloisi A.M., Aurilio C., Bachiocco V., Biasi G., Fiorenzani P., Pace M.C., Paci V., Pari G., Passavanti G., Ravaioli L., Sindaco G., Vellucci R., Ceccarelli I. Endocrine consequences of opioid therapy. Psychoneuroendocrinology 2009, 34:S162-S168.
4. Aloisi A.M., Pari G., Ceccarelli I., Vecchi I., Ietta F., Lodi L., Paulesu L. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (mif). Pain 2005, 115:142-151.
5. Bernal S.A., Morgan M.M., Craft R.M. Pag mu opioid receptor activation underlies sex differences in morphine antinociception. Behav. Brain Res. 2007, 177:126-133.
6. Bhanot R., Wilkinson M. Opiatergic control of gonadotropin secretion during puberty in the rat: a neurochemical basis for the hypothalamic 'gonadostat'?. Endocrinology 1983, 113:596-603.
7. Buckman S.G., Hodgson S.R., Hofford R.S., Eitan S. Increased elevated plus maze open-arm time in mice during spontaneous morphine withdrawal. Behav. Brain Res. 2009, 197:454-456.
8. Budziszewska B., Leśkiewicz M., Jaworska-Feil L., Lasoń W. The effect of n-nitro-l-arginine methyl ester on morphine-induced changes in the plasma corticosterone and testosterone levels in mice. Exp. Clin. Endocrinol. Diabetes 1999, 107:75-79.
9. Cantiello M., Giantin M., Carletti M., Lopparelli R.M., Capolongo F., Lasserre F., Bollo E., Nebbia C., Martin P.G.P., Pineau T., Dacasto M. Effects of dexamethasone, administered for growth promoting purposes, upon the hepatic cytochrome p450 3a expression in the veal calf. Biochem. Pharmacol. 2009, 77:451-463.
10. Carballo-Márquez A., Vale-Martínez A., Guillazo-Blanch G., Martí-Nicolovius M. Muscarinic transmission in the basolateral amygdala is necessary for the acquisition of socially transmitted food preferences in rats. Neurobiol. Learn. Mem. 2009, 91:98-101.
11. Cicero T.J. Effects of exogenous and endogenous opiates on the hypothalamic-pituitary-gonadal axis in the male. Fed. Proc. 1980, 39:2551-2554.
12. Cicero T.J., Adams M.L., Giordano A., Miller B.T., O'Connor L., Nock B. Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring. J. Pharmacol. Exp. Ther. 1991, 256:1086-1093.
13. Cicero T.J., Meyer E.R., Miller B.T., Bell R.D. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists. J. Pharmacol. Exp. Ther. 1988, 246:14-20.
14. Cicero T.J., O'Connor L., Nock B., Adams M.L., Miller B.T., Bell R.D., Meyer E.R. Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat. J. Pharmacol. Exp. Ther. 1989, 248:256-261.
15. Cicero T.J., Schainker B.A., Meyer E.R. Endogenous opioids participate in the regulation of the hypothalamic-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone. Endocrinology 1979, 104:1286-1291.
16. Contet C., Filliol D., Matifas A., Kieffer B.L. Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity. Neuropharmacology 2008, 54:475-486.
17. Craft R.M., Clark J.L., Hart S.P., Pinckney M.K. Sex differences in locomotor effects of morphine in the rat. Pharmacol. Biochem. Behav. 2006, 85:850-858.
18. Craft R.M., Stratmann J.A., Bartok R.E., Walpole T.I., King S.J. Sex differences in development of morphine tolerance and dependence in the rat. Psychopharmacology 1999, 143:1-7.
19. Donham R.S., Sarafidis E.H., Stetson M.H. Naloxone administration to female hamsters advances puberty by enhancing luteinizing hormone release. Proc. Soc. Exp. Biol. Med. 1986, 182:291-295.
20. Eisenberg R.M., Sparber S.B. Changes in plasma corticosterone levels as a measure of acute dependence upon levorphanol in rats. J. Pharmacol. Exp. Ther. 1979, 211:364-369.
21. El-kadi A.O., Sharif S.I. The influence of various experimental conditions on the expression of naloxone-induced withdrawal symptoms in mice. Gen. Pharmacol. 1994, 25:1505-1510.
22. Felip C.M., Rodríguez-Arias M., Espejo E.F., Miñarro J., Stinus L. Naloxone-induced opiate withdrawal produces long-lasting and context-independent changes in aggressive and social behaviors of postdependent male mice. Behav. Neurosci. 2000, 114:424-430.
23. Fuertes G., Laorden M.L., Milanés M.V. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal. Neuroendocrinology 2000, 71:60-67.
24. Gabriel S.M., Berglund L.A., Kalra S.P., Kalra P.S., Simpkins J.W. The influence of chronic morphine treatment on the negative feedback regulation of gonadotropin secretion by gonadal steroids. Endocrinology 1986, 119:2762-2767.
25. Gerendai I. Modulation of testicular functions by testicular opioid peptides. J. Physiol. Pharmacol. 1991, 42:427-437.
26. Gonzalvez M.L., Milaneós M.V., Martinez-Pinero M.G., Marión M.T., Vargas M.L. Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal. Brain Res. 1994, 647:199-203.
27. Guidotti A., Dong E., Matsumoto K., Pinna G., Rasmusson A.M., Costa E. The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5[alpha]-dihydroprogesterone in psychiatric disorders. Brain Res. Rev. 2001, 37:110-115.
28. Gunderson M.P., Kohno S., Blumberg B., Iguchi T., Guillette J.L.J. Up-regulation of the alligator cyp3a77 gene by toxaphene and dexamethasone and its short term effect on plasma testosterone concentrations. Aquat. Toxicol. 2006, 78:272-283.
29. Hodgson S.R., Hofford R.S., Norris C.J., Eitan S. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal. Behav. Pharmacol. 2008, 19:805-811.
30. Hodgson S.R., Hofford R.S., Roberts K.W., Wellman P.J., Eitan S. Socially-induced morphine pseudo-sensitization in adolescent mice. Behav. Pharmacol. 2010.
31. Hodgson S.R., Hofford R.S., Wellman P.J., Eitan S. Different affective response to opioid withdrawal in adolescent and adult mice. Life Sci. 2009, 84:52-60.
32. Kalra P.S., Sahu A., Kalra S.P. Opiate-induced hypersensitivity to testosterone feedback: pituitary involvement. Endocrinology 1988, 122:997-1003.
33. Kepler K.L., Kest B., Kiefel J.M., Cooper M.L., Bodnar R.J. Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacol. Biochem. Behav. 1989, 34:119-127.
34. Kest B., Palmese C.A., Hopkins E., Adler M., Juni A. Assessment of acute and chronic morphine dependence in male and female mice. Pharmacol. Biochem. Behav. 2001, 70:149-156.
35. Kishioka S., Nishida S., Fukunaga Y., Yamamoto H. Quantitative properties of plasma corticosterone elevation induced by naloxone-precipitated withdrawal in morphine-dependent rats. Jpn. J. Pharmacol. 1994, 66:257-263.
36. Kletter G.B., Foster C.M., Brown M.B., Padmanabhan V., Beitins I.Z., Marshall J.C., Kelch R.P. Naloxone does not reverse the suppressive effects of testosterone infusion on luteinizing hormone secretion in pubertal boys. J. Clin. Endocrinol. Metab. 1991, 73:1241-1247.
37. Kletter G.B., Padmanabhan V., Beitins I.Z., Marshall J.C., Kelch R.P., Foster C.M. Acute effects of estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys. J. Clin. Endocrinol. Metab. 1997, 82:4010-4014.
38. Knapska E., Nikolaev E., Boguszewski P., Walasek G., Blaszczyk J., Kaczmarek L., Werka T. Between-subject transfer of emotional information evokes specific pattern of amygdala activation. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3858-3862.
39. Laviola G., Adriani W., Morley-Fletcher S., Terranova M. Peculiar response of adolescent mice to acute and chronic stress and to amphetamine: evidence of sex differences. Behav. Brain Res. 2002, 130:117-125.
40. Lehmann K.P., Phillips S., Sar M., Foster P.M.D., Gaido K.W. Dose-dependent alterations in gene expression and testosterone synthesis in the fetal testes of male rats exposed to di (n-butyl) phthalate. Toxicol. Sci. 2004, 81:60-68.
41. Loyd D.R., Wang X., Murphy A.Z. Sex differences in micro-opioid receptor expression in the rat midbrain periaqueductal gray are essential for eliciting sex differences in morphine analgesia. J. Neurosci. 2008, 28:14007-14017.
42. Maggi R., Limonta P., Dondi D., Piva F. Modulation of the binding characteristics of hypothalamic mu opioid receptors in rats by gonadal steroids. J. Steroid Biochem. Mol. Biol. 1991, 40:113-121.
43. Maldonado R., Fournié-Zaluski M.C., Roques B.P. Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter. Naunyn Schmiedebergs Arch. Pharmacol. 1992, 345:466-472.
44. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996, 383:819-823.
45. Mujica-Parodi L.R., Strey H.H., Frederick B., Savoy R., Cox D., Botanov Y., Tolkunov D., Rubin D., Weber J. Chemosensory cues to conspecific emotional stress activate amygdala in humans. PLoS ONE 2009, 4:e6415.
46. Nayebi A.R.M., Rezazadeh H. Effect of testosterone on morphine withdrawal syndrome in rats. Asian J. Androl. 2008, 10:765-769.
47. Neal B.S., Sparber S.B. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine. J. Pharmacol. Exp. Ther. 1986, 236:157-165.
48. Rasheed A., Tareen I.A. Effects of heroin on thyroid function, cortisol and testosterone level in addicts. Pol. J. Pharmacol. 1995, 47:441-444.
49. Razzoli M., Roncari E., Guidi A., Carboni L., Arban R., Gerrard P., Bacchi F. Conditioning properties of social subordination in rats: behavioral and biochemical correlates of anxiety. Horm. Behav. 2006, 50:245-251.
50. Rodríguez-Arias M., Pinazo J., Miñarro J., Stinus L. Effects of sch 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice. Pharmacol. Biochem. Behav. 1999, 64:123-130.
51. Rosellini R.A., Svare B.B., Rhodes M.E., Frye C.A. The testosterone metabolite and neurosteroid 3[alpha]-androstanediol may mediate the effects of testosterone on conditioned place preference. Brain Res. Rev. 2001, 37:162-171.
52. Sadeghi M., Sianati S., Anaraki D.K., Ghasemi M., Paydar M.J., Sharif B., Mehr S.E., Dehpour A.R. Study of morphine-induced dependence in gonadectomized male and female mice. Pharmacol. Biochem. Behav. 2009, 91:604-609.
53. SAMHSA, 2009. The NSDUH Report: Trends in Nonmedical Use of Prescription Pain Relievers: 2002 to 2007. Substance Abuse and Mental Health Services Administration: Office of Applied Studies, Rockville, MD.
54. Shane R., Bernal S.Y., Rozengurtel S., Bodnar R.J. Estrus phase differences in female rats in morphine antinociception elicited from the ventrolateral periaqueductal gray. Int. J. Neurosci. 2007, 117:811-822.
55. Sirinathsinghji D.J.S., Motta M., Martini L. Induction of precocious puberty in the female rat after chronic naloxone administration during the neonatal period: the opiate 'brake' on prepubertal gonadotrophin secretion. J. Endocrinol. 1985, 104:299-307.
56. South S.M., Edwards S.R., Smith M.T. Antinociception versus serum concentration relationships following acute administration of intravenous morphine in male and female Sprague-Dawley rats: differences between the tail flick and hot plate nociceptive tests. Clin. Exp. Pharmacol. Physiol. 2009, 36:20-28.
57. Spanagel R., Almeida O.F., Bartl C., Shippenberg T.S. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology (Berlin) 1994, 115:121-127.
58. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000, 24:417-463.
59. Sukhotina I.A. Morphine withdrawal-facilitated aggression is attenuated by morphine-conditioned stimuli. Pharmacol. Biochem. Behav. 2001, 68:93-98.
60. Suzuki H., Han S.D., Lucas L.R. Increased 5-ht1b receptor density in the basolateral amygdala of passive observer rats exposed to aggression. Brain Res. Bull. 2010, 83:38-43.
61. Trudeau V.L., Meijer J.C., van de Wiel D.F.M., Bevers M.M., Erkens J.H.F. Effects of morphine and naloxone on plasma levels of lh, fsh, prolactin and growth hormone in the immature male pig. J. Endocrinol. 1988, 119:501-508.
62. Verdi J., Ahmadiani A. Finasteride, a 5alpha-reductase inhibitor, potentiates antinociceptive effects of morphine, prevents the development of morphine tolerance and attenuates abstinence behavior in the rat. Horm. Behav. 2007, 51:605-610.
63. Vivian J.A., Miczek K.A. Diazepam and gepirone selectively attenuate either 20-32 or 32-64kHz ultrasonic vocalizations during aggressive encounters. Psychopharmacology (Berlin) 1993, 112:66-73.
64. Weintraub A., Singaravelu J., Bhatnagar S. Enduring and sex-specific effects of adolescent social isolation in rats on adult stress reactivity. Brain Res. 2010, 1343:83-92.
65. Wood R.I. Anabolic-androgenic steroid dependence? Insights from animals and humans. Front. Neuroendocrinol. 2008, 29:490-506.
66. Xiao-feng Z., Nai-qiang Q., Jing Z., Zi L., Yang Z. Di (n-butyl) phthalate inhibits testosterone synthesis through a glucocorticoid-mediated pathway in rats. Int. J. Toxicol. 2009, 28:448-456.
67. Yilmaz B., Konar V., Kutlu S., Sandal S., Canpolat S., Gezen M.R., Kelestimur H. Influence of chronic morphine exposure on serum lh, fsh, testosterone levels, and body and testicular weights in the developing male rat. Arch. Androl. 1999, 43:189-196.